Edward Lifesciences Corp halts enrollment in clinical trial

May 19 (Reuters) - Heart device maker Edward Lifesciences Corp said it had stopped enrolling patients in a study testing its experimental heart valve due to the formation of blood clots.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.